Mitochondrial preconditioning: A potential neuroprotective strategy

Frontiers in Aging Neuroscience

Volumn 2, Issue AUG, 2010, Pages

  Correia, Sónia C ^a,b   Carvalho, Cristina ^a,b   Cardoso, Susana ^a,b   Santos, Renato X ^a,b   Santos, Maria S ^a,b   Oliveira, Catarina R ^a,c   Perry, George ^d,e   Zhu, Xiongwei ^e   Smith, Mark A ^e   Moreira, Paula I ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mitochondria; MitoKATP channels; Neurodegeneration; Neuroprotection; Preconditioning; Reactive oxygen species

Indexed keywords

EID: 79955962818     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2010.00138     Document Type: Review

References (178)

1. Allen, K. L., Almeida, A., Bates, T. E., and Clark J. B. (1995). Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischemia. J. Neurochem. 64, 2222-2229.
2. Allen, R. G., and Tresini, M. (2000). Oxidative stress and gene regulation. Free Radic. Biol. Med. 28, 463-499.
3. Almeida, A., Allen, K. L., Bates, T. E., and Clark, J. B. (1995). Effect of reperfusion following cerebral ischemia on the activity of the mitochondrial respiratory chain in the gerbil brain. J. Neurochem. 65, 1698-1703.
4. Anandatheerthavarada, H. K., Biswas, G., Robin, M. A., and Avadhani, N. G. (2003). Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 41-54.
5. Ardehali, H., and O'Rourke, B. (2005). Mitochondrial K(ATP) channels in cell survival and death. J. Mol. Cell. Cardiol. 39, 7-16.
6. Auchampach, J. A., Grover, G. J., and Gross, G. J. (1992). Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc. Res. 26, 1054-1062.
7. Bajgar, R., Seetharaman, S., Kowaltowski, A. J., Garlid, K. D., and Paucek, P. (2001). Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J. Biol. Chem. 276, 33369-33374.
8. Banerjee, R., Starkov, A. A., Beal, M. F., and Thomas, B. (2009). Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim. Biophys. Acta 1792, 651-663.
9. Barroso, N., Campos, Y., Huertas, R., Esteban, J., Molina, J. A., Alonso, A., Gutierrez-Rivas, E., and Arenas, J. (1993). Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease. Clin. Chem. 39, 667-669.
10. Beal, M. F. (2005). Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58, 495-505.
11. Bell, E. L., Klimova, T. A., Eisenbart, J., Moraes, C. T., Murphy, M. P., Budinger, G. R., and Chandel, N. S. (2007). The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 177, 1029-1036.
12. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
13. Blandini, F., Nappi, G., and Greenamyre, J. T. (1998). Quantitative study of mitochondrial complex I in platelets of parkinsonian patients. Mov. Disord. 13, 11-15.
14. Bolaños, J. P., Moro, M. A., Lizasoain, I., and Almeida, A. (2009). Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications. Adv. Drug Deliv. Rev. 61, 1299-1315.
15. Bosetti, F., Brizzi, F., Barogi, S., Mancuso, M., Siciliano, G., Tendi, E. A., Murri, L., Rapoport, S. I., and Solaini, G. (2002). Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol. Aging 23, 371-376.
16. Brunelle, J. K., Bell, E. L., Quesada, N. M., Vercauteren, K., Tiranti, V., Zeviani, M., Scarpulla, R. C., and Chandel, N. S. (2005). Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1, 409-414.
17. Bubber, P., Haroutunian, V., Fisch, G., Blass, J. P., and Gibson, G. E. (2005). Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann. Neurol. 57, 695-703.
18. Busija, D. W., Gaspar, T., Domoki, F., Katakam, P. V., and Bari, F. (2008). Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning. Adv. Drug Deliv. Rev. 60, 1471-1477.
19. Busija, D. W., Katakam, P., Rajapakse, N. C., Kis, B., Grover, G., Domoki, F., and Bari, F. (2005). Effects of ATP-sensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria. Brain Res. Bull. 66, 85-90.
20. Cadet, J. L., and Krasnova, I. N. (2009). Cellular and molecular neurobiology of brain preconditioning. Mol. Neurobiol. 39, 50-61.
21. Cardoso, S. M., Moreira, P. I., Agostinho, P., Pereira, C., and Oliveira, C. R. (2005). Neurodegenerative pathways in Parkinson's disease: therapeutic strategies. Curr. Drug Targets CNS Neurol. Disord. 4, 405-419.
22. Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., and Yan, S. D. (2005). Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19, 2040-2041.
23. Chan, P. H. (2004). Future targets and cascades for neuroprotective strategies. Stroke 35, 2748-2750.
24. Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., and Schumacker, P. T. (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA. 95, 11715-11720.
25. Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., and Schumacker, P. T. (2000). Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275, 25130-25138.
26. Chi, X., Sutton, E. T., Hellermann, G., and Price, J. M. (2000). Potassium channel openers prevent beta-amyloid toxicity in bovine vascular endothelial cells. Neurosci. Lett. 290, 9-12.
27. Correia, S. C., and Moreira, P. I. (2010). Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration? J. Neurochem. 112, 1-12.
28. Coskun, P. E., Beal, M. F., and Wallace, D. C. (2004). Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl. Acad. Sci. U.S.A. 101, 10726-10731.
29. Crouch, P. J., Blake, R., Duce, J. A., Ciccotosto, G. D., Li, Q. X., Barnham, K. J., Curtain, C. C., Cherny, R. A., Cappai, R., Dyrks, T., Masters, C. L., and Trounce, I. A. (2005). Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J. Neurosci. 25, 672-679.
30. Dauer, W., Kholodilov, N., Vila, M., Trillat, A. C., Goodchild, R., Larsen, K. E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C. A., Rocha, M., Jackson-Lewis, V., Hersch, S., Sulzer, D., Przedborski, S., Burke, R., and Hen, R. (2002). Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl. Acad. Sci. U.S.A. 99, 14524-14529.
31. Debska, G., May, R., Kicinska, A., Szewczyk, A., Elger, C. E., and Kunz, W. S. (2001). Potassium channel openers depolarize hippocampal mitochondria. Brain Res. 892, 42-50.
32. de Lau, L. M., Giesbergen, P. C., de Rijk, M. C., Hofman, A., Koudstaal, P. J., and Breteler, M. M. (2004). Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63, 1240-1244.
33. de Rijk, M. C., Rocca, W. A., Anderson, D. W., Melcon, M. O., Breteler, M. M., and Maraganore, D. M. (1997). A population perspective on diagnostic criteria for Parkinson's disease. Neurology 48, 1277-1281.
34. Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., and Anandatheerthavarada, H. K. (2006). Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26, 9057-9068.
35. Dirnagl, U., Becker, K., and Meisel, A. (2009). Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 8, 398-412.
36. Dirnagl, U., Iadecola, C., and Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
37. Dirnagl, U., and Meisel, A. (2008). Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning? Neuropharmacology 55, 334-344.
38. Domoki, F., Bari, F., Nagy, K., Busija, D. W., and Siklos, L. (2004). Diazoxide prevents mitochondrial swelling and Ca (2+) accumulation in CAI pyramidal cells after cerebral ischemia in newborn pigs. Brain Res. 1019, 97-104.
39. Domoki, F., Perciaccante, J. V., Veltkamp, R., Bari, F., and Busija, D. W. (1999). Mitochondrial potassium channel opener diazoxide preserves neuronal-vascular function after cerebral ischemia in newborn pigs. Stroke 30, 2713-2718.
40. Donnan, G. A., Fisher, M., Macleod, M., and Davis, S. M. (2008). Stroke. Lancet 371, 1612-1623.
41. Droge, W. (2002). Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95.
42. Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., Gunn-Moore, F. J., Vonsattel, J. P., Arancio, O., Chen, J. X., and Yan, S. D. (2008). Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med. 14, 1097-1105.
43. Dux, E., Mies, G., Hossmann, K. A., and Siklos, L. (1987). Calcium in the mitochondria following brief ischemia of gerbil brain. Neurosci. Lett. 78, 295-300.
44. Ekstrand, M. I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F. S., Trifunovic, A., Hoffer, B., Cullheim, S., Mohammed, A. H., Olson, L., and Larsson, N. G. (2007). Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc. Natl. Acad. Sci. USA. 104, 1325-1330.
45. Falkevall, A., Alikhani, N., Bhushan, S., Pavlov, P. F., Busch, K., Johnson, K. A., Eneqvist, T., Tjernberg, L., Ankarcrona, M., and Glaser, E. (2006). Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. J. Biol. Chem. 281, 29096-29104.
46. Findeis, M. A. (2007). The role of amyloid beta peptide 42 in Alzheimer's disease. Pharmacol. Ther. 116, 266-286.
47. Fiskum, G. (2000). Mitochondrial participation in ischemic and traumatic neuronal cell death. J. Neurotrauma 17, 843-855.
48. Furuichi, T., Liu, W., Shi, H., Miyake, M., and Liu, K. J. (2005). Generation of hydrogen peroxide during brief oxygen-glucose deprivation induces preconditioning neuronal protection in primary cultured neurons. J. Neurosci. Res. 79, 816-824.
49. + channel in cardiac function and cardioprotection. Biochim. Biophys. Acta 1606, 1-21.
50. + channels. Possible mechanism of cardioprotection. Circ. Res. 81, 1072-1082.
51. Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D. Y., Hunter, R. L., Gerhardt, G. A., Smith, C. D., Slevin, J. T., and Prince, T. S. (2007). Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann. Neurol. 63, 184-192.
52. Gáspár, T., Domoki, F., Lenti, L., Katakam, P. V., Snipes, J. A., Bari, F., and Busija, D. W. (2009). Immediate neuronal preconditioning by NS1619. Brain Res. 1285, 196-207.
53. Gáspár, T., Katakam, P., Snipes, J. A., Kis, B., Domoki, F., Bari, F., and Busija, D. W. (2008a). Delayed neuronal preconditioning by NS1619 is independent of calcium activated potassium channels. J. Neurochem. 105, 1115-1128.
54. Gáspár, T., Snipes, J. A., Busija, A. R., Kis, B., Domoki, F., Bari, F., and Busija, D. W. (2008b). ROS-independent preconditioning in neurons via activation of mitoKATP channels by BMS-191095. J. Cereb. Blood Flow Metab. 28, 1090-1103.
55. Gibson, G. E., Sheu, K. F., and Blass, J. P. (1998). Abnormalities of mitochondrial enzymes in Alzheimer disease. J. Neural Transm. 105, 855-870.
56. + channel openers protect hippocampal neurons against oxidative injury and amyloid beta-peptide toxicity. Brain Res. 706, 328-332.
57. Green, D. R., and Kroemer, G. (2004). The pathophysiology of mitochondrial cell death. Science 305, 626-629.
58. Green, D. R., and Reed, J. C. (1998). Mitochondria and apoptosis. Science 281, 1309-1312.
59. Greenfield, J. P., Gross, R. S., Gouras, G. K., and Xu, H. (2000). Cellular and molecular basis of beta-amyloid precursor protein metabolism. Front. Biosci. 5, 72-83.
60. Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., and Schumacker, P. T. (2005). Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401-408.
61. Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., and Shults, C. W. (1995). Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann. Neurol. 37, 714-722.
62. Hamblet, N. S., Ragland. B., Ali, M., Conyers, B., and Castora, F. J. (2006). Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single-strand conformation polymorphism. Electrophoresis 27, 398-408.
63. Hansson Petersen, C. A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P. F., Alafuzoff, I., Leinonen, V., Ito, A., Winblad, B., Glaser, E., and Ankarcrona, M. (2008). The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. U.S.A. 105, 13145-13150.
64. Horiguchi, T., Kis, B., Rajapakse, N., Shimizu, K., and Busija, D. W. (2003). Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke 34, 1015-1020.
65. Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., and Masliah, E. (2000). Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157, 401-410.
66. Huang, H. M., Ou, H. C., Xu, H., Chen, H. L., Fowler, C., and Gibson, G. E. (2003). Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death. J. Neurosci. Res. 74, 309-317.
67. Inoue, I., Nagase, H., Kishi, K., and Higuti, T. (1991). ATP-sensitive K channel mitochondrial inner membrane. Nature 352, 244-247.
68. Jaburek, M., Yarov-Yarovoy, V., Paucek, P., and Garlid, K. D. (1998). State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate. J. Biol. Chem. 273, 13578-13582.
69. Jin, J., Hulette, C., Wang, Y., Zhang, T., Pan, C., Wadhwa, R., and Zhang, J. (2006). Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol. Cell. Proteomics 5, 1193-1204.
70. Jou, M. J. (2008). Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes. Adv. Drug Deliv. Rev. 60, 1512-1526.
71. Kis, B., Nagy, K., Snipes, J. A., Rajapakse, N., Horiguchi, T., Grover, G. J., and Busija, D. W. (2004). The mitochondrial KATP channel opener BMS191095 induces neuronal preconditioning. Neuroreport 15, 345-349.
72. Kis, B., Rajapakse, N., Snipes, J. A., Nagy, K., Horiguchi, T., and Busija, D. W. (2003). Diazoxide induces delayed preconditioning in cultured rat cortical neurons. J. Neurochem. 87, 969-980.
73. Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L. J., Wilson, J. M., DiStefano, L. M., and Nobrega, J. N. (1992). Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59, 776-779.
74. Klimova, T., and Chandel, N. S. (2008). Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 15, 660-666.
75. Klivenyi, P., Siwek, D., Gardian, G., Yang, L., Starkov, A., Cleren, C., Ferrante, R. J., Kowall, N. W., Abeliovich, A., and Beal, M. F. (2006). Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol. Dis. 21, 541-548.
76. Knott, A. B., Perkins, G., Schwarzenbacher, R., and Bossy-Wetzel, E. (2008). Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505-518.
77. Kowaltowski, A. J. (2000). Alternative mitochondrial functions in cell physiopathology: beyond ATP production. Braz. J. Med. Biol. Res. 33, 241-250.
78. Krige, D., Carroll, M. T., Cooper, J. M., Marsden, C. D., and Schapira, A. H. (1992). Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann. Neurol. 32, 782-788.
79. Kulawiak, B., and Bednarczyk, P. (2005). Reconstitution of brain mitochondria inner membrane into planar lipid bilayer. Acta Neurobiol. Exp. 65, 271-276.
80. Kuroda, S., Katsura, K. I., Tsuchidate, R., and Siesjo, B. K. (1996). Secondary bioenergetic failure after transient focal ischaemia is due to mitochondrial injury. Acta Physiol. Scand. 156, 149-150.
81. + channel in the brain. Brain Res. 19, 27-36.
82. Lin, M. T., and Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795.
83. Lin, M. T., Simon, D. K., Ahn, C. H., Kim, L. M., and Beal, M. F. (2002). High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11, 133-145.
84. Liou, A. K., Clark, R. S., Henshall, D. C., Yin, X. M., and Chen, J. (2003). To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog. Neurobiol. 69, 103-142.
85. Lipton, P. (1999). Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568.
86. Liu, D., Lu, C., Wan, R., Auyeung, W. W., and Mattson, M. P. (2002). Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J. Cereb. Blood Flow Metab. 22, 431-443.
87. Liu, W., Vives-Bauza, C., Acín-Peréz, R., Yamamoto, A., Tan, Y., Li, Y., Magrané, J., Stavarache, M. A., Shaffer, S., Chang, S., Kaplitt, M. G., Huang, X. Y., Beal, M. F., Manfredi, G., and Li, C. (2009). PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease. PLoS ONE 4, 4597. doi:10.1371/journal.pone.0004597.
88. Liu, X., Wu, J. Y., Zhou, F., Sun, X. L., Yao, H. H., Yang, Y., Ding, J. H., and Hu, G. (2006). The regulation of rotenone-induced inflammatory factor production by ATP-sensitive potassium channel expressed in BV-2 cells. Neurosci. Lett. 394, 131-135.
89. Lo, E. H., Dalkara, T., and Moskowitz, M. A. (2003). Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415.
90. Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S., Gunn-Moore, F., Lue, L. F., Walker, D. G., Kuppusamy, P., Zewier, Z. L., Arancio, O., Stern, D., Yan, S. S., and Wu, H. (2004). ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452.
91. Ma, G., and Chen, S. (2004). Diazoxide and N omega-nitro-l-arginine counteracted A beta 1-42-induced cytotoxicity. Neuroreport 15, 1813-1817.
92. Ma, G., Gao, J., Fu, Q., Jiang, L., Wang, R., Zhang, Y., and Liu, K. (2009). Diazoxide reverses the enhanced expression of K(ATP) subunits in cholinergic neurons caused by exposure to Abeta(1-42). Neurochem. Res. (in press).
93. Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., and Reddy, P. H. (2006). Mitochondria are a direct site of Abeta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437-1449.
94. Mann, V. M., Cooper, J. M., Daniel, S. E., Srai, K., Jenner, P., Marsden, C. D., and Schapira, A. H. (1994). Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann. Neurol. 36, 876-881.
95. Mansfield, K. D., Guzy, R. D., Pan, Y., Young, R. M., Cash, T. P., Schumacker, P. T., and Simon, M. C. (2005). Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-a activation. Cell Metab. 1, 393-399.
96. Maurer, I., Zierz, S., and Möller, H. J. (2000). A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging 21, 455-462.
97. Mayanagi, K., Gaspar, T., Katakam, P. V., Kis, B., and Busija, D. W. (2007a). The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 27, 348-355.
98. Mayanagi, K., Gaspar, T., Katakam, P. V., and Busija, D. W. (2007b). Systemic administration of diazoxide induces delayed preconditioning against transient focal cerebral ischemia in rats. Brain Res. 1168, 106-111.
99. Migliore, L., and Coppedè, F. (2009). Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat. Res. 674, 73-84.
100. Mitsios, N., Gaffney, J., Krupinski, J., Mathias, R., Wang, Q., Hayward, S., Rubio, F., Kumar, P., Kumar, S., and Slevin, M. (2007). Expression of signaling molecules associated with apoptosis in human ischemic stroke tissue. Cell Biochem. Biophys. 47, 73-86.
101. Mizuno, Y., Matuda, S., Yoshino, H., Mori, H., Hattori, N., and Ikebe, S. (1994). An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35, 204-210.
102. Moisoi, N., Klupsch, K., Fedele, V., East, P., Sharma, S., Renton, A., Plun-Favreau, H., Edwards, R. E., Teismann, P., Esposti, M. D., Morrison, A. D., Wood, N. W., Downward, J., and Martins, L. M. (2009). Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ. 16, 449-464.
103. Moreira, P. I., Duarte, A. I., Santos, M. S., Rego, A. C., and Oliveira, C. R. (2009). An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J. Alzheimers Dis. 16, 741-761.
104. Moreira, P. I., Honda, K., Zhu, X., Nunomura, A., Casadesus, G., Smith, M. A., and Perry, G. (2006). Brain and brawn: parallels in oxidative strength. Neurology 66, 97-101.
105. Moreira, P. I., Santos, M. S., Moreno, A., and Oliveira, C. (2001). Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci. Rep. 21, 789-800.
106. Moreira, P. I., Santos, M. S., Moreno, A., Rego, A. C., and Oliveira, C. (2002). Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J. Neurosci. Res. 69, 257-267.
107. Moreira, P. I., Santos, M. S., and Oliveira, C. R. (2007). Alzheimer's disease: a lesson from mitochondrial dysfunction. Antioxid. Redox Signal. 9, 1621-1630.
108. Moreira, P. I., Zhu, X., Wang, X., Lee, H. G., Nunomura, A., Petersen, R. B., Perry, G., and Smith, M. A. (2010). Mitochondria: a therapeutic target in neurodegeneration. Biochim. Biophys. Acta 1802, 212-220.
109. Murphy, A. N., Fiskum, G., and Beal, M. F. (1999). Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J. Cereb. Blood Flow Metab. 19, 231-245.
110. Nagy, K., Kis, B., Rajapakse, N. C., Bari, F., and Busija, D. W. (2004). Diazoxide preconditioning protects against neuronal cell death by attenuation of oxidative stress upon glutamate stimulation. J. Neurosci. Res. 76, 697-704.
111. Nelson, C., and Silverstein, F. S. (1994). Acute disruption of cytochrome oxidase activity in brain in a perinatal rat stroke model. Pediatr. Res. 36, 12-19.
112. Nicholls, D. G. (2009). Mitochondrial calcium function and dysfunction in the central nervous system. Biochim. Biophys. Acta 1787, 1416-1424.
113. Nicotera, P., and Lipton, S. A. (1999). Excitotoxins in neuronal apoptosis and necrosis. J. Cereb. Blood Flow Metab. 19, 583-591.
114. Nunomura, A., Honda, K., Takeda, A., Hirai, K., Zhu, X., Smith, M.A., and Perry, G. (2006). Oxidative damage to RNA in neurodegenerative diseases. J. Biomed. Biotechnol. 2006, 82323.
115. Ohtsuki, T., Matsumoto, M., Kuwabara, K., Kitagawa, K., Suzuki, K., Taniguchi, N., and Kamada, T. (1992). Influence of oxidative stress on induced tolerance to ischemia in gerbil hippocampal neurons. Brain Res. 599, 246-252.
116. Oldenburg, O., Cohen, M. V., Yellon, D. M., and Downey, J. M. (2002). Mitochondrial KATP channels: role in cardioprotection. Cardiovasc. Res. 55, 429-437.
117. Parker, W. D. Jr., Boyson, S. J., and Parks, J. K. (1989). Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719-723.
118. Parker, W. D. Jr., Mahr, N. J., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A., and Cullum, C. M. (1994). Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44, 1086-1090.
119. Patel, H. H., and Gross, G. J. (2001). Diazoxide induced cardioprotection: what comes first, KATP channels or reactive oxygen species? Cardiovasc. Res. 51, 633-636.
120. Penn, A. M., Roberts, T., Hodder, J., Allen, P. S., Zhu, G., and Martin, W. R. (1995). Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle. Neurology 45, 2097-2099.
121. Peters, O., Back, T., Lindauer, U., Busch, C., Megow, D., Dreier, J., and Dirnagl, U. (1998). Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 18, 196-205.
122. Petrozzi, L., Ricci, G., Giglioli, N. J., Siciliano, G., and Mancuso, M. (2007). Mitochondria and neurodegeneration. Biosci. Rep. 27, 87-104.
123. Przedborski, S., Vial, M., and Jackson-Lewis, V. (2003). Neurodegeneration: what is it and where are we? J. Clin. Invest. 111, 3-10.
124. Puka-Sundvall, M., Gajkowska, B., Cholewinski, M., Blomgren, K., Lazarewicz, J. W., and Hagberg, H. (2000). Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats. Brain Res. Dev. Brain Res. 125, 31-41.
125. Qiu, X., Chen, Y., and Zhou, M. (2001). Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer's disease. Brain Res. 893, 261-263.
126. Rami, A., Bechmann, I., and Stehle, J. H. (2008). Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Prog. Neurobiol. 85, 273-296.
127. Ravagnan, L., Roumier, T., and Kroemer, G. (2002). Mitochondria, the killer organelles and their weapons. J. Cell. Physiol. 192, 131-137.
128. Raval, A. P., Dave, K. R., Defazio, R. A., and Pérez-Pinzón, M. A. (2007). EpsilonPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus. Brain Res. 1184, 345-353.
129. Ravati, A., Ahlemeyer, B., Becker, A., Klumpp, S., and Krieglstein, J. (2001). Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB. J. Neurochem. 78, 909-919.
130. Ravati, A., Ahlemeyer, B., Becker, A., and Krieglstein, J. (2000). Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res. 866, 23-32.
131. Sairanen, T., Karjalainen-Lindsberg, M. L., Paetau, A., Ijas, P., and Lindsberg, P. J. (2006). Apoptosis dominant in the periinfarct area of human ischaemic stroke-a possible target of antiapoptotic treatments. Brain 129, 189-199.
132. Samavati, L., Monick, M. M., Sanlioglu, S., Buettner, G. R., Oberley, L. W., and Hunninghake, G. W. (2002). Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am. J. Physiol. Cell Physiol. 283, 273-281.
133. Schapira, A. H. (2008). Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 7, 97-109.
134. Schapira, A. H., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., and Marsden, C. D. (1989). Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
135. 2+rise upon hypoxia/reoxygenation for functional breakdown and morphological disintegration. J. Biol. Chem. 278, 25454-25460.
136. Schinzel, A. C., Takeuchi, O., Huang, Z., Fisher, J. K., Zhou, Z., Rubens, J., Hetz, C., Danial, N. N., Moskowitz, M. A., and Korsmeyer, S. J. (2005). Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 102, 12005-12010.
137. Selkoe, D. J. (2001). Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 3, 75-80.
138. Sherer, T. B., Richardson, J. R., Testa, C. M., Seo, B. B., Panov, A. V., Yagi, T., Matsuno-Yagi, A., Miller, G. W., and Greenamyre, J. T. (2007). Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J. Neurochem. 100, 1469-1479.
139. Shimizu, K., Lacza, Z., Rajapakse, N., Horiguchi, T., Snipes, J., and Busija, D. W. (2002). MitoKATP opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat. Am. J. Physiol. 283, 1005-1011.
140. Siesjö, B. K., Katsura, K. I., Zhao, Q., Folbergrova, J., Pahlmark, K., Siesjö, P., and Smith, M. L. (1995). Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J. Neurotrauma 12, 943-956.
141. 2+] and [H+] in the hippocampus during recovery from short-term, transient ischemia. J. Cereb. Blood Flow Metab. 12, 759-772.
142. Simerabet, M., Robin, E., Aristi, I., Adamczyk, S., Tavernier, B., Vallet, B., Bordet, R., and Lebuffe, G. (2008). Preconditioning by an in situ administration of hydrogen peroxide: involvement of reactive oxygen species and mitochondrial ATP-dependent potassium channel in a cerebral ischemia-reperfusion model. Brain Res. 1240, 177-184.
143. Simpkins, J. W., Yi, K. D., Yang, S., and Dykens, J. A. (2009). Mitochondrial mechanisms of estrogen neuroprotection. Biochim. Biophys. Acta (in press).
144. Sims, N. R. (1991). Selective impairment of respiration in mitochondria isolated from brain subregions following transient forebrain ischemia in the rat. J. Neurochem. 56, 1835-1844.
145. Sims, N. R., and Pulsinelli, W. A. (1987). Altered mitochondrial respiration in selectively vulnerable brain subregions following transient forebrain ischemia in the rat. J. Neurochem. 49, 1367-1374.
146. Smith, M. A., Perry, G., Richey, P. L., Sayre, L. M., Anderson, V. E., Beal, M. F., and Kowall, N. (1996). Oxidative damage in Alzheimer's. Nature 382, 120-121.
147. Soane, L., Kahraman, S., Kristian, T., and Fiskum, G. (2007). Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders. J. Neurosci. Res. 85, 3407-3415.
148. Song, D. D., Shults, C. W., Sisk, A., Rockenstein, E., and Masliah, E. (2004). Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186, 158-172.
149. Suleiman, M. S., Halestrap, A. P., and Griffiths, E. J. (2001). Mitochondria: a target for myocardial protection. Pharmacol. Ther. 89, 29-46.
150. Sultana, R., Perluigi, M., and Butterfield, D. A. (2006). Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 8, 2021-2037.
151. Swerdlow, R. H., Parks, J. K., Miller, S. W., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J.P. Jr., Davis, R. E., and Parker, W. D. Jr. (1996). Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663-671.
152. Szewczyk, A., and Wojtczak, L. (2002). Mitochondria as a pharmacological target. Pharmacol. Rev. 54, 101-127.
153. Tai, K. K., McCrossan, Z. A., and Abbott, G. W. (2003). Activation of mitochondrial ATP-sensitive potassium channels increases cell viability against rotenone-induced cell death. J. Neurochem. 84, 1193-1200.
154. Tai, K. K., and Truong DD. (2002). Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease. J. Neurosci. Res. 69, 559-566.
155. Takuma, K., Yao, J., Huang, J., Xu, H., Chen, X., Luddy, J., Trillat, A. C., Stern, D. M., Arancio, O., and Yan, S. S. (2005). ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J. 19, 597-598.
156. Tang, X. Q., Chen, J., Tang, E. H., Feng, J. Q., and Chen, P. X. (2005a). Hydrogen peroxide preconditioning protects PC12 cells against apoptosis induced by oxidative stress. Sheng Li Xue Bao 57, 211-216.
157. Tang, X. Q., Feng, J. Q., Chen, J., Chen, P. X., Zhi, J. L., Cui, Y., Guo, R. X., and Yu, H. M. (2005b). Protection of oxidative preconditioning against apoptosis induced by H2O2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2. Brain Res. 1057, 57-64.
158. Taylor, D. J., Krige, D., Barnes, P. R., Kemp, G. J., Carroll, M. T., Mann, V. M., Cooper, J. M., Marsden, C. D., and Schapira, A. H. (1994). A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease. J. Neurol. Sci. 125, 77-81.
159. Thomas, B., and Beal, M. F. (2007). Parkinson's disease. Hum. Mol. Genet. 16, 183-194.
160. Trimmer, P. A., Borland, M. K., Keeney, P. M., Bennett, J.P. Jr., and Parker, W. D. Jr. (2004). Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. J. Neurochem. 88, 800-812.
161. Tsujimoto, Y., and Shimizu, S. (2007). Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12, 835-840.
162. Valla, J., Schneider, L., Niedzielko, T., Coon, K. D., Caselli, R., Sabbagh, M. N., Ahern, G. L., Baxter, L., Alexander, G., Walker, D. G., and Reiman, E. M. (2006). Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 6, 323-330.
163. Vanden Hoek, T. L., Becker, L. B., Shao, Z., Li, C., and Schumacker, P. T. (1998). Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J. Biol. Chem. 273, 18092-18098.
164. Wang, J., Xiong, S., Xie, C., Markesbery, W. R., and Lovell, M. A. (2005). Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J. Neurochem. 93, 953-962.
165. Wang, X., Su, B., Fujioka, H., and Zhu, X. (2008a). Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am. J. Pathol. 173, 470-482.
166. Wang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., Casadesus, G., and Zhu, X. (2008b). Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U.S.A. 105, 19318-19323.
167. Wang, X., Su, B., Zheng, L., Perry, G., Smith, M. A., and Zhu, X. (2009a). The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J. Neurochem. 109, 153-159.
168. Wang, X., Su, B., Lee, H. G., Li, X., Perry, G., Smith, M. A., and Zhu, X. (2009b). Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 29, 9090-9103.
169. Wiegand, F., Liao, W., Busch, C., Castell, S., Knapp, F., Lindauer, U., Megow, D., Meisel, A., Redetzky, A., Ruscher, K., Trendelenburg, G., Victorov, I., Riepe, M., Diener, H. C., and Dirnagl, U. (1999). Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 1229-1237.
170. + channel is mediated by inhibiting the mitochondrial permeability transition pore. Neurosci. Lett. 402, 184-189.
171. Xie, J., Duan, L., Qian, X., Huang, X., Ding, J., and Hu, G. (2009). K(ATP) channel openers protect mesencephalic neurons against MPP(+)-induced cytotoxicity via inhibition of ROS production. J. Neurosci. Res. 88, 428-437.
172. Yan, S. D., and Stern, D. M. (2005). Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int. J. Exp. Pathol. 86, 161-171.
173. Yang, Y., Liu, X., Long, Y., Wang, F., Ding, J. H., Liu, S. Y., Sun, Y. H., Yao, H. H., Wang, H., Wu, J., and Hu, G. (2006). Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. Int. J. Neuropsychopharmacol. 9, 51-61.
174. + channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ. Res. 73, 1193-1201.
175. Yoshino, H., Nakagawa-Hattori, Y., Kondo, T., and Mizuno, Y. (1992). Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J. Neural Transm. Park. Dis. Dement. Sect. 4, 27-34.
176. Zaidan, E., and Sims, N. R. (1994). The calcium content of mitochondria from brain subregions following short-term forebrain ischemia and recirculation in the rat. J. Neurochem. 63, 1812-1819.
177. Zhang, D. X., and Gutterman, D. D. (2007). Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 292, 2023-2031.
178. Zhang, D. X., Chen, Y. F., Campbell, W. B., Zou, A. P., Gross, G. J., and Li, P. L. (2001). Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ. Res. 89, 1177-1183.